Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose

Hypoxia is a characteristic feature of solid tumors and an important causation of resistance to chemotherapy and photodynamic therapy (PDT). It is challenging to develop efficient functional nanomaterials for tumor oxygenation and therapeutic applications. Methods: Through disulfide reconfiguration...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zhenyu, Tian, Hao, Liu, Lanlan, Chen, Zhikuan, Liang, Ruijing, Chen, Ze, Wu, Zhihao, Ma, Aiqing, Zheng, Mingbin, Cai, Lintao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037038/
https://www.ncbi.nlm.nih.gov/pubmed/30026868
http://dx.doi.org/10.7150/thno.25409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037038/
https://www.ncbi.nlm.nih.gov/pubmed/30026868
http://dx.doi.org/10.7150/thno.25409

Ejemplares similares